Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Neuromolecular Med. 2019 Jun 13;21(4):445–453. doi: 10.1007/s12017-019-08554-6

Fig. 1: Flow cytometric gating.

Fig. 1:

Representative images from brain tissue to depict the gating strategy used to identify A) Th17 (CD4+, IL-17A+), B) γδTCR (CD3+, γδTCR+), C) Th1 (CD3+, IFNy+), D) Th2 (CD3+, IL-4+), and E) Treg (CD4+, FOXP3+).